Lung Cancer | Tumor

No Small Challenge: Emerging Therapies in Small Cell Lung Cancer

April 21st 2021, 3:00pm


In recent years, research in treating small cell lung cancer has broadened, bringing emerging therapies like immunotherapy to the forefront.

Cell-Based Therapies May ‘Level the Playing Field’ in Non-Small Cell Lung Cancer

April 20th 2021, 6:00pm


Even with all the recent advances in targeted therapies and immunotherapy drugs, patients with non-small cell lung cancer still need more treatment options. Although it’s early, cell-based therapies have shown some promise, with more research underway.

Obesity May Be Associated with Increased Cancer Mortality in Most Cancers; Lower in Others

April 14th 2021, 6:00pm


Recent study results demonstrated an possible association between a high BMI and risk of cancer and overall mortality, though patients with obesity and lung cancer, renal cell carcinoma and melanoma were found to have a lower risk of death than patients with the same cancers without obesity.

Webinar Recap: Know Your Lung Cancer: Accelerating Education and Access for Biomarker Testing

April 13th 2021, 6:00pm


On Feb. 18, CURE hosted a webinar focused on educating patients on biomarker testing. Here, we highlight key takeaways from our panelists.

CURE®'s Educated Patient® Lung Cancer Summit At a Glance

April 10th 2021, 3:00pm


Take a look back at CURE®’s Educated Patient® Lung Cancer Summit with this roundup of stories that highlight what was discussed at this half-day virtual event.

Addressing Aspects Outside of Treatment, Looking Ahead in Lung Cancer Care

April 7th 2021, 12:00pm


CURE spoke with the LUNGevity Foundation about lung cancer and its treatments, as well as aspects to cancer outside of day-to-day care.

CURE’s Top Stories: March 2021

April 1st 2021, 1:00pm


Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for March 2021.

‘Significant Unmet Needs’ Not Addressed With FDA Approval of Lorbrena

March 31st 2021, 6:00pm


The FDA recently approved an expanded indication for Lorbrena as a first-line treatment option for a subset of lung cancer that has spread to the brain. Although the drug is effective for some patients, experts debate its widespread use.

Opdivo With or Without Yervoy Did Not Prolong Survival in Small Cell Lung Cancer

March 29th 2021, 9:00pm


Previously, treatments for patients with extensive-disease small cell lung cancer were limited with a poor prognosis. Researchers sought to investigate if Opdivo plus Yervoy or Opdivo alone would improve survival.

CURE’s Clinical Trial Corner: March 2021

March 25th 2021, 1:00pm


Here is a list of some recent trials that launched within the cancer space in March.